-
Je něco špatně v tomto záznamu ?
Importance of genetic background of oxysterol signaling in cancer
P. Holy, A. Kloudova, P. Soucek,
Jazyk angličtina Země Francie
Typ dokumentu časopisecké články, přehledy
Grantová podpora
NV17-28470A
MZ0
CEP - Centrální evidence projektů
- MeSH
- časná detekce nádoru MeSH
- lidé MeSH
- nádorové biomarkery metabolismus MeSH
- nádory diagnóza genetika metabolismus MeSH
- oxysteroly metabolismus MeSH
- signální transdukce * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Oxysterols, oxygenated derivatives of cholesterol, are formed in the human body or ingested. Experimental evidence suggests that due to their diverse functions, e.g. modulating the activity of receptors such as liver X receptors, oxysterol-binding and metabolizing proteins, and several ATP binding cassette transporters, oxysterols may contribute to a number of human disorders including cancer. Genetic variability of oxysterol pathways represents another side of this process, affecting carcinogenesis and cancer progression. This review summarizes information about both the physiological role of oxysterol pathway genes and observed associations between their genetic variability and cancer incidence, progression, and therapy outcome. Besides candidate gene studies, results of genome-wide association studies are presented as well. The survey of available data shows some potential genetic biomarkers that, if clinically validated, may allow the stratification of individuals into genetically defined groups for prediction of individual cancer risk and subsequent screening strategies for early diagnosis.
3rd Faculty of Medicine Charles University Ruska 87 100 00 Prague 10 Czech Republic
Toxicogenomics Unit National Institute of Public Health Srobarova 48 100 42 Prague 10 Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19000752
- 003
- CZ-PrNML
- 005
- 20190114094730.0
- 007
- ta
- 008
- 190107s2018 fr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.biochi.2018.04.023 $2 doi
- 035 __
- $a (PubMed)29746893
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a fr
- 100 1_
- $a Holy, P $u Toxicogenomics Unit, National Institute of Public Health, Srobarova 48, 100 42, Prague 10, Czech Republic; Third Faculty of Medicine, Charles University, Ruska 87, 100 00, Prague 10, Czech Republic.
- 245 10
- $a Importance of genetic background of oxysterol signaling in cancer / $c P. Holy, A. Kloudova, P. Soucek,
- 520 9_
- $a Oxysterols, oxygenated derivatives of cholesterol, are formed in the human body or ingested. Experimental evidence suggests that due to their diverse functions, e.g. modulating the activity of receptors such as liver X receptors, oxysterol-binding and metabolizing proteins, and several ATP binding cassette transporters, oxysterols may contribute to a number of human disorders including cancer. Genetic variability of oxysterol pathways represents another side of this process, affecting carcinogenesis and cancer progression. This review summarizes information about both the physiological role of oxysterol pathway genes and observed associations between their genetic variability and cancer incidence, progression, and therapy outcome. Besides candidate gene studies, results of genome-wide association studies are presented as well. The survey of available data shows some potential genetic biomarkers that, if clinically validated, may allow the stratification of individuals into genetically defined groups for prediction of individual cancer risk and subsequent screening strategies for early diagnosis.
- 650 _2
- $a nádorové biomarkery $x metabolismus $7 D014408
- 650 _2
- $a časná detekce nádoru $7 D055088
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nádory $x diagnóza $x genetika $x metabolismus $7 D009369
- 650 _2
- $a oxysteroly $x metabolismus $7 D000072376
- 650 12
- $a signální transdukce $7 D015398
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Kloudova, A $u Toxicogenomics Unit, National Institute of Public Health, Srobarova 48, 100 42, Prague 10, Czech Republic; Third Faculty of Medicine, Charles University, Ruska 87, 100 00, Prague 10, Czech Republic.
- 700 1_
- $a Soucek, P $u Toxicogenomics Unit, National Institute of Public Health, Srobarova 48, 100 42, Prague 10, Czech Republic; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 76, Pilsen, 32300, Czech Republic. Electronic address: pavel.soucek@szu.cz.
- 773 0_
- $w MED00009325 $t Biochimie $x 1638-6183 $g Roč. 153, č. - (2018), s. 109-138
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29746893 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190107 $b ABA008
- 991 __
- $a 20190114094939 $b ABA008
- 999 __
- $a ok $b bmc $g 1364765 $s 1038875
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 153 $c - $d 109-138 $e 20180507 $i 1638-6183 $m Biochimie $n Biochimie $x MED00009325
- GRA __
- $a NV17-28470A $p MZ0
- LZP __
- $a Pubmed-20190107